RT @uptoTate: SPIRIT-P1&P2 studies showed IXE effective in treating axPsA. When do you consider IL17i in your treatm
Tweet Content
SPIRIT-P1&P2 studies showed IXE effective in treating axPsA. When do you consider IL17i in your treatment algorithm in axPsA (as the predominant domain?) Poster #POS1045 #EULAR2021 @RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off